BOSTON--(BUSINESS WIRE)--OvaScience™, a fertility company applying innovative science to improve the quality of eggs and increase the success of in vitro fertilization (IVF), today announced that the company has been invited to present at the Lazard Capital Markets 8th Annual Healthcare Conference, being held November 16-17 at The Pierre Hotel in New York City. Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will present an overview of the company at 10:30 a.m. on Wednesday, November 16.
